CIK: 0001400240
Total reported value
$1.2B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | MRNA | Moderna INC | Stock-Healthcare | 58.71% | -21.90% | — | |
| 2 | ✓ | Sigilon Therapeutics INC | Stock-Other | 9.07% | — | — | |
| 3 | MCRB1EUR | Seres Therapeutics INC | Stock-Other | 6.54% | — | -31.98% | |
| 4 | RUBYUSD | Rubius Therapeutics INC | Stock-Other | 5.29% | — | — | |
| 5 | ✓ | Evelo Biosciences INC | Stock-Other | 5.04% | — | — | |
| 6 | FHTX | Foghorn Therapeutics INC | Stock-Other | 4.68% | -15.90% | — | |
| 7 | DNLI | Denali Therapeutics INC | Stock-Other | 4.16% | — | -54.35% | |
| 8 | KLDO | Kaleido Biosciences INC | Stock-Other | 3.21% | — | — | |
| 9 | 32W | Codiak Biosciences INC | Stock-Other | 1.53% | — | — | |
| 10 | ✓ | Axcella Health INC Com New | Stock-Other | 1.19% | — | — | |
| 11 | SYRSEUR | Syros Pharmaceuticals INC | Stock-Other | 0.58% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Evelo Biosciences INC | +1.7% | — | Unchanged |
| 2 | RUBYUSD | Rubius Therapeutics INC | 0% | — | Unchanged |
| 3 | SYRSEUR | Syros Pharmaceuticals INC | -0.1% | — | Unchanged |
| 4 | ✓ | Axcella Health INC Com New | -0.4% | — | Unchanged |
| 5 | MRNA | Moderna INC | -1.6% | — | Unchanged |
| 6 | DNLI | Denali Therapeutics INC | -1.8% | -54.35% | Trim |
| 7 | KLDO | Kaleido Biosciences INC | -2.7% | — | Unchanged |
| 8 | MCRB1EUR | Seres Therapeutics INC | -10.3% | -31.98% | Trim |
| 9 | ✓ | Sigilon Therapeutics INC | — | NEW | New buy |
| 10 | FHTX | Foghorn Therapeutics INC | — | NEW | New buy |
| 11 | 32W | Codiak Biosciences INC | — | NEW | New buy |